Search

Your search keyword '"Atanasov, Petar"' showing total 274 results

Search Constraints

Start Over You searched for: Author "Atanasov, Petar" Remove constraint Author: "Atanasov, Petar"
274 results on '"Atanasov, Petar"'

Search Results

1. Rare host variants in ciliary expressed genes contribute to COVID-19 severity in Bulgarian patients

5. Rare host variants in ciliary expressed genes contribute to COVID-19 severity in Bulgarian patients

7. Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis.

9. MULTIVARIATE ANALYSIS OF DISCRIMINATION AND SOCIAL INDICATORS IN THE WESTERN BALKANS COUNTRIES.

10. Fabrication of Nanostructures Consisting of Composite Nanoparticles by Open-Air PLD.

12. Prevention of cardiovascular diseases

15. Sex-specific Impact of 17β-estradiol and Testosterone Levels on Inflammation and Injury in Acute Myocardial Infarction

23. Antitumor and antioxidant activity of some metal complex compounds

25. List of Contributors

27. Comparative analysis of comorbidity, surgical complications, pharmacotherapeutic needs, and rehabilitation requirements in transabdominal preperitoneal hernia repair versus conventional operative treatment-current results and benefits.

28. Anxiety in the emergency medical practice - its psychiatric and somatic origin, comorbidities, behavior and treatment.

29. Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review.

30. Aluminum nanostructures for 355 nm surface‐enhanced Raman spectroscopy of fluorescing chemicals.

31. Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement.

32. Risk Factors for Pulmonary Arterial Hypertension in Patients With Systemic Lupus Erythematosus: A Systematic Review and Expert Consensus.

33. Figure 2 from: Pantileeva D, Rangelova D, Atanasov P, Mircheva S, Ivanov I, Chaneva M, Obreshkova D, Ivanova S, Milanov S, Kazalakova K, Dimitrov V, Petkova V, Baltov A, Petrov S (2023) Logistical challenges with an emphasis on organizing specialized triage in the conditions of a newly emerging, epidemiologically significant infectious pathogen for humans – SARS-CoV2. Pharmacia 70(1): 129-137. https://doi.org/10.3897/pharmacia.70.e101353

34. Figure 1 from: Pantileeva D, Rangelova D, Atanasov P, Mircheva S, Ivanov I, Chaneva M, Obreshkova D, Ivanova S, Milanov S, Kazalakova K, Dimitrov V, Petkova V, Baltov A, Petrov S (2023) Logistical challenges with an emphasis on organizing specialized triage in the conditions of a newly emerging, epidemiologically significant infectious pathogen for humans – SARS-CoV2. Pharmacia 70(1): 129-137. https://doi.org/10.3897/pharmacia.70.e101353

35. Logistical challenges with an emphasis on organizing specialized triage in the conditions of a newly emerging, epidemiologically significant infectious pathogen for humans – SARS-CoV2

37. Laparoscopic IPOMPLUS repair-current outcomes and complications.

38. Operative management of acute cholecystitis in pregnancy: Case report.

39. Monitoring the change in the quality of life of patients with post-COVID syndrome by influence on their functional status.

40. Immune response – genesis, duration, and strength in patients with moderate and severe coronavirus infection of different age groups.

42. Macedonian Reform Perspectives

43. Figure 2 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095

44. Supplementary material 1 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095

45. Figure 4 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095

46. Figure 5 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095

47. Figure 3 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095

48. Figure 6 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095

49. Figure 1 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095

Catalog

Books, media, physical & digital resources